Sandra Sauer

1.3k total citations
54 papers, 583 citations indexed

About

Sandra Sauer is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sandra Sauer has authored 54 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 17 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Sandra Sauer's work include Multiple Myeloma Research and Treatments (35 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cancer Treatment and Pharmacology (8 papers). Sandra Sauer is often cited by papers focused on Multiple Myeloma Research and Treatments (35 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cancer Treatment and Pharmacology (8 papers). Sandra Sauer collaborates with scholars based in Germany, United States and Austria. Sandra Sauer's co-authors include Hartmut Goldschmidt, Jens Hillengaß, Maximilian Merz, Stefan Delorme, Carsten Müller‐Tidow, Dirk Hose, Kai Neben, Karin Jordan, Marc‐Steffen Raab and Gerlinde Egerer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Sandra Sauer

47 papers receiving 573 citations

Peers

Countries citing papers authored by Sandra Sauer

Since Specialization

Citations

This map shows the geographic impact of Sandra Sauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Sauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Sauer more than expected).

Fields of papers citing papers by Sandra Sauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Sauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Sauer. The network helps show where Sandra Sauer may publish in the future.

Co-authorship network of co-authors of Sandra Sauer

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Sauer. A scholar is included among the top collaborators of Sandra Sauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Sauer. Sandra Sauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sequential BCMA CAR T-cell therapy in refractory multiple myeloma 2025 ·Blood Advances ·(unknown), Udo Holtick, (unknown), (unknown), Hyatt Balke‐Want, (unknown), (unknown), Sandra Sauer, Raphael Teipel, Malte von Bonin, Michael Hallek, Christof Scheid, Philipp Gödel	0
2	Advanced Automated Model for Robust Bone Marrow Segmentation in Whole-body MRI 2025 ·Academic Radiology ·(unknown), (unknown), (unknown), (unknown), Niels Weinhold, Sandra Sauer, (unknown), Marc‐Steffen Raab, K. Elias, Tim Frederik Weber, Hartmut Goldschmidt, Heinz-Peter Schlemmer, Klaus Maier‐Hein, Stefan Delorme, Peter Neher, (unknown)	1
3	Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance 2024 ·Blood Cancer Journal ·(unknown), Thomas Hielscher, (unknown), Iris Breitkreutz, Sandra Sauer, Marc S. Raab, Carsten Müller‐Tidow, Hartmut Goldschmidt, K. Elias	1
4	The CAR-Hematotox As a Risk Model to Predict Early Complications and Outcome after Bispecific T-Cell Engager Therapy in Relapsed/Refractory Multiple Myeloma 2024 ·Blood ·(unknown), (unknown), (unknown), (unknown), Mirco Friedrich, Niels Weinhold, K. Martin Kortüm, Carsten Müller‐Tidow, Hermann Einsele, Sandra Sauer, Leo Rasche, Marc S. Raab	0
5	MRD By Flow Cytometry and FDG-PET/CT for the Post-Induction Response Assessment in Patients with Multiple Myeloma Treated in the Phase 3 GMMG HD7 Study 2024 ·Blood ·(unknown), Christos Sachpekidis, Annette Kopp‐Schneider, (unknown), Sandra Sauer, (unknown), Michael Hundemer, Niels Weinhold, Jens Hillengaß, Marc S. Raab, Antonia Dimitrakopoulou‐Strauss, (unknown)	1
6	Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma 2024 ·European Radiology ·(unknown), Christos Sachpekidis, Lukas John, Peter Neher, (unknown), (unknown), Daniel Paech, Antonia Dimitrakopoulou‐Strauss, Felix T. Kurz, Sandra Sauer, Marc S. Raab, H Schlemmer, (unknown), Niels Weinhold	0
7	Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·Lukas John, Sandra Sauer, Ute Hegenbart, Peter Dreger, Michael Hundemer, Carsten Müller‐Tidow, Anita Schmitt, Michael Schmitt, Marc S. Raab, Stefan Schönland	4
8	Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma 2023 ·Hematological Oncology ·Joseph Kauer, (unknown), Katharina Kriegsmann, Niels Weinhold, (unknown), Carsten Müller‐Tidow, Hartmut Goldschmidt, Marc‐Steffen Raab, Sandra Sauer	5
9	Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients 2023 ·Transfusion Medicine and Hemotherapy ·Sandra Sauer, (unknown), (unknown), Carsten Müller‐Tidow, Anita Schmitt, Joseph Kauer, Katharina Kriegsmann	2
10	Orodispersible films – Recent developments and new applications in drug delivery and therapy 2022 ·Biochemical Pharmacology ·(unknown), Sandra Sauer, (unknown), Andreas H. Wagner	36
11	The Spatial Heterogeneity in Newly Diagnosed Multiple Myeloma Patients - from Sub-Clonal Architecture to the Immune Microenvironment 2021 ·Blood ·Lukas John, Alexandra M. Poos, Stephan M. Tirier, Jan‐Philipp Mallm, Nina Prokoph, Alexander Brobeil, Raphael Lutz, Sabrina Schumacher, Simon Steiger, Katharina Bauer, Anja Baumann, Christoph Rehnitz, Carsten Müller‐Tidow, Hartmut Goldschmidt, Stefanie Huhn, Karsten Rippe, Marc‐Steffen Raab, Sandra Sauer, Niels Weinhold	3
12	Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT 2021 ·European Radiology ·(unknown), Stephan Skornitzke, Theresa Mokry, Sandra Sauer, Wolfram Stiller, Johanna Nattenmüller, Hans‐Ulrich Kauczor, Tim Frederik Weber, (unknown)	11
13	Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma Patients 2021 ·Transplantation and Cellular Therapy ·Sandra Sauer, (unknown), Alexandra D Jensen, (unknown), Petra Pavel, Karin Jordan, Anita Schmitt, Mark Kriegsmann, Patrick Wuchter, Hartmut Goldschmidt, Carsten Müller‐Tidow, Katharina Kriegsmann	7
14	Cryostorage to What End? – Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients 2020 ·Transfusion Medicine and Hemotherapy ·Katharina Kriegsmann, Petra Pavel, (unknown), Anita Schmitt, Sandra Sauer, Mark Kriegsmann, Thomas Brückner, Stefan Klein, Harald Klüter, Carsten Müller‐Tidow, Patrick Wuchter	0
15	Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment 2020 ·Cancers ·Katharina Kriegsmann, Michael Hundemer, (unknown), (unknown), (unknown), (unknown), Sandra Sauer, Uta Bertsch, Britta Besemer, Roland Fenk, Mathias Hänel, Markus Munder, Katja Weisel, (unknown), Andreas Neubauer, Carsten Müller‐Tidow, Marc S. Raab, Hartmut Goldschmidt, Stefanie Huhn	12
16	Prevention and Management of Chemotherapy-Induced Polyneuropathy 2019 ·Breast Care ·Berit Jordan, Franziska Jahn, Sandra Sauer, Karin Jordan	32
17	High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting 2017 ·BMC Cancer ·Katharina Lisenko, Sandra Sauer, Thomas Brückner, Gerlinde Egerer, Hartmut Goldschmidt, Jens Hillengaß, (unknown), (unknown), Mathias Witzens‐Harig, Anthony D. Ho, Patrick Wuchter	14
18	A Furan-Based Lewis-Y-(CD174)-Saccharide Mimetic Inhibits Endothelial Functions and In Vitro Angiogenesis 2015 ·Advances in Clinical and Experimental Medicine ·Sandra Sauer, Tobias Meißner, Thomas Moehler	4
19	Extratumoral Spiral Fixed Wire Marking of Small Pulmonary Nodules for Thoracoscopic Resection 2008 ·The Thoracic and Cardiovascular Surgeon ·Markus Hirschburger, Sandra Sauer, Thilo Schwandner, (unknown), (unknown), (unknown), H. F. Janssen, Vicente Grau, W. A. Stertmann, Wigbert S. Rau, Winfried Padberg	6
20	Involvement of α 1‐2‐fucosyltransferase I (FUT1) and surface‐expressed lewis^y (CD174) in first endothelial cell–cell contacts during angiogenesis 2008 ·Journal of Cellular Physiology ·Thomas Moehler, Sandra Sauer, Maximilian Witzel, Mindaugas Andrulis, Juan J. García‐Vallejo, Rainer Grobholz, Martina Willhauck‐Fleckenstein, Andreas Greiner, Hartmut Goldschmidt, Reinhard Schwartz‐Albiez	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact